222 related articles for article (PubMed ID: 32583294)
1. Liraglutide: New Perspectives for the Treatment of Polycystic Ovary Syndrome.
Papaetis GS; Filippou PK; Constantinidou KG; Stylianou CS
Clin Drug Investig; 2020 Aug; 40(8):695-713. PubMed ID: 32583294
[TBL] [Abstract][Full Text] [Related]
2. A 12-week treatment with the long-acting glucagon-like peptide 1 receptor agonist liraglutide leads to significant weight loss in a subset of obese women with newly diagnosed polycystic ovary syndrome.
Jensterle M; Kravos NA; Pfeifer M; Kocjan T; Janez A
Hormones (Athens); 2015; 14(1):81-90. PubMed ID: 25885106
[TBL] [Abstract][Full Text] [Related]
3. Effect of liraglutide on ectopic fat in polycystic ovary syndrome: A randomized clinical trial.
Frøssing S; Nylander M; Chabanova E; Frystyk J; Holst JJ; Kistorp C; Skouby SO; Faber J
Diabetes Obes Metab; 2018 Jan; 20(1):215-218. PubMed ID: 28681988
[TBL] [Abstract][Full Text] [Related]
4. A systematic review of GLP-1 on anthropometrics, metabolic and endocrine parameters in patients with PCOS.
Bader S; Bhatti R; Mussa B; Abusanana S
Womens Health (Lond); 2024; 20():17455057241234530. PubMed ID: 38444070
[TBL] [Abstract][Full Text] [Related]
5. Low dose of liraglutide combined with metformin leads to a significant weight loss in Chinese Han women with polycystic ovary syndrome: a retrospective study.
Long X; Liu H; Xiong W; Li W; He H; Fu T; Li X; Chen C; Zhang L; Liu Y
Gynecol Endocrinol; 2023 Jun; 39(1):2223648. PubMed ID: 37406658
[TBL] [Abstract][Full Text] [Related]
6. Short-term intervention with liraglutide improved eating behavior in obese women with polycystic ovary syndrome.
Jensterle M; Kocjan T; Kravos NA; Pfeifer M; Janez A
Endocr Res; 2015; 40(3):133-8. PubMed ID: 25330463
[TBL] [Abstract][Full Text] [Related]
7. Obesity, Polycystic Ovary Syndrome, and Infertility: A New Avenue for GLP-1 Receptor Agonists.
Cena H; Chiovato L; Nappi RE
J Clin Endocrinol Metab; 2020 Aug; 105(8):e2695-709. PubMed ID: 32442310
[TBL] [Abstract][Full Text] [Related]
8. Dipeptidyl Peptidase-4 Inhibitor Sitagliptin Prevented Weight Regain in Obese Women with Polycystic Ovary Syndrome Previously Treated with Liraglutide: A Pilot Randomized Study.
Ferjan S; Janez A; Jensterle M
Metab Syndr Relat Disord; 2017 Dec; 15(10):515-520. PubMed ID: 29064743
[TBL] [Abstract][Full Text] [Related]
9. Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in the Treatment of Obese Women with Polycystic Ovary Syndrome.
Tzotzas T; Karras SN; Katsiki N
Curr Vasc Pharmacol; 2017; 15(3):218-229. PubMed ID: 28003008
[TBL] [Abstract][Full Text] [Related]
10. Effects of liraglutide on ovarian dysfunction in polycystic ovary syndrome: a randomized clinical trial.
Nylander M; Frøssing S; Clausen HV; Kistorp C; Faber J; Skouby SO
Reprod Biomed Online; 2017 Jul; 35(1):121-127. PubMed ID: 28479118
[TBL] [Abstract][Full Text] [Related]
11. A systematic review of GLP-1 agonists on the metabolic syndrome in women with polycystic ovaries.
Niafar M; Pourafkari L; Porhomayon J; Nader N
Arch Gynecol Obstet; 2016 Mar; 293(3):509-15. PubMed ID: 26660657
[TBL] [Abstract][Full Text] [Related]
12. [Liraglutide in polycystic ovary syndrome].
Gómez-Pérez AM; Fernández-García JC; Mancha Doblas I; Tinahones FJ
Med Clin (Barc); 2014 Sep; 143(6):283-4. PubMed ID: 24456922
[No Abstract] [Full Text] [Related]
13. Short term monotherapy with GLP-1 receptor agonist liraglutide or PDE 4 inhibitor roflumilast is superior to metformin in weight loss in obese PCOS women: a pilot randomized study.
Jensterle M; Salamun V; Kocjan T; Vrtacnik Bokal E; Janez A
J Ovarian Res; 2015 Jun; 8():32. PubMed ID: 26032655
[TBL] [Abstract][Full Text] [Related]
14. 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial.
le Roux CW; Astrup A; Fujioka K; Greenway F; Lau DCW; Van Gaal L; Ortiz RV; Wilding JPH; Skjøth TV; Manning LS; Pi-Sunyer X;
Lancet; 2017 Apr; 389(10077):1399-1409. PubMed ID: 28237263
[TBL] [Abstract][Full Text] [Related]
15. The role of glucagon-like peptide-1 in reproduction: from physiology to therapeutic perspective.
Jensterle M; Janez A; Fliers E; DeVries JH; Vrtacnik-Bokal E; Siegelaar SE
Hum Reprod Update; 2019 Jul; 25(4):504-517. PubMed ID: 31260047
[TBL] [Abstract][Full Text] [Related]
16. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
[TBL] [Abstract][Full Text] [Related]
17. Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study.
Tang T; Glanville J; Hayden CJ; White D; Barth JH; Balen AH
Hum Reprod; 2006 Jan; 21(1):80-9. PubMed ID: 16199429
[TBL] [Abstract][Full Text] [Related]
18. Short-term effectiveness of low dose liraglutide in combination with metformin versus high dose liraglutide alone in treatment of obese PCOS: randomized trial.
Jensterle M; Kravos NA; Goričar K; Janez A
BMC Endocr Disord; 2017 Jan; 17(1):5. PubMed ID: 28143456
[TBL] [Abstract][Full Text] [Related]
19. Impact of Metformin on IVF Outcomes in Overweight and Obese Women With Polycystic Ovary Syndrome: A Randomized Double-Blind Controlled Trial.
Abdalmageed OS; Farghaly TA; Abdelaleem AA; Abdelmagied AE; Ali MK; Abbas AM
Reprod Sci; 2019 Oct; 26(10):1336-1342. PubMed ID: 29576001
[TBL] [Abstract][Full Text] [Related]
20. Comparison of single and combined treatment with exenatide and metformin on menstrual cyclicity in overweight women with polycystic ovary syndrome.
Elkind-Hirsch K; Marrioneaux O; Bhushan M; Vernor D; Bhushan R
J Clin Endocrinol Metab; 2008 Jul; 93(7):2670-8. PubMed ID: 18460557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
